Statements (59)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Genetics
|
gptkbp:advocated_for |
gptkb:scientists
bioethicists |
gptkbp:allows |
targeted DNA modification
|
gptkbp:based_on |
bacterial immune system
|
gptkbp:business_model |
germline editing
designer babies |
gptkbp:can_be_combined_with |
other gene editing technologies
|
gptkbp:can_be_used_to |
treat genetic disorders
create genetically modified organisms insert genes knock out genes modify gene expression |
gptkbp:developed_by |
gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna |
gptkbp:first_introduced |
gptkb:2012
|
gptkbp:future_prospects |
improve food security
revolutionize medicine enhance crop resilience |
gptkbp:has_applications_in |
gptkb:biotechnology
gptkb:Medicine pharmaceutical development |
gptkbp:has_limitations |
off-target effects
ethical implications delivery methods |
https://www.w3.org/2000/01/rdf-schema#label |
CRISPR
|
gptkbp:is_associated_with |
scientific breakthroughs
biological safety concerns genetic modification controversies |
gptkbp:is_criticized_for |
gptkb:activists
regulatory bodies |
gptkbp:is_explored_in |
gptkb:cancer_treatment
plant breeding HIV treatment sickle cell disease treatment muscular dystrophy treatment agricultural pest control cystic fibrosis treatment hereditary diseases treatment |
gptkbp:is_part_of |
gptkb:biotechnology
molecular biology genomics |
gptkbp:is_popular_in |
universities
research institutions biotech companies |
gptkbp:is_related_to |
Cas9 protein
guide RNA |
gptkbp:is_subject_to |
gptkb:regulations
patents |
gptkbp:is_supported_by |
gptkb:National_Science_Foundation
gptkb:National_Institutes_of_Health |
gptkbp:is_used_in |
gptkb:gene_therapy
clinical trials agricultural biotechnology |
gptkbp:used_for |
gene editing
|
gptkbp:used_in |
agriculture
biomedical research |
gptkbp:bfsParent |
gptkb:Bionicle
|
gptkbp:bfsLayer |
4
|